What Is Fanconi Syndrome in Dogs: Causes & Treatment

Fanconi syndrome in dogs is a kidney disorder where the tiny tubes responsible for reclaiming nutrients from urine stop working properly, causing the body to lose glucose, amino acids, electrolytes, and other essential substances through urination. The condition can be inherited or acquired, and while it shares some symptoms with diabetes, the underlying problem is completely different. With proper management, most affected dogs maintain a good quality of life and a near-normal lifespan.

How Healthy Kidneys Work and What Goes Wrong

Your dog’s kidneys filter blood through millions of tiny structures. After filtering, the proximal tubules (the first stretch of tubing after each filter) are supposed to reclaim about 80% of the useful substances before they’re lost to urine. These tubules pull back glucose, amino acids, phosphate, uric acid, bicarbonate, and small proteins that the body still needs.

In Fanconi syndrome, this reclamation system breaks down. The proximal tubules can no longer reabsorb these solutes efficiently, so they spill into the urine. One of the most important losses is bicarbonate, the body’s main acid buffer. Normally, nearly all filtered bicarbonate is recaptured. When the proximal tubules fail, excess bicarbonate floods downstream segments of the kidney that aren’t equipped to handle the overflow. The result is a condition called metabolic acidosis, where the blood becomes too acidic. Left unchecked, this acid buildup drives many of the more serious complications of the disease.

Inherited vs. Acquired Causes

The Basenji Connection

Basenjis are by far the breed most associated with Fanconi syndrome, with an estimated prevalence of about 10%. Researchers have traced the inherited form to a 317-base-pair deletion in the last exon of a gene called FAN1. Dogs that carry two copies of this deletion (one from each parent) develop the syndrome. A study that genotyped 78 Basenjis of known disease status found almost complete concordance between having two copies of the deletion and developing clinical signs. A DNA test is available, and breeders can have dogs classified as clear, carrier, or affected before making breeding decisions.

Other breeds occasionally develop inherited Fanconi syndrome, but it is far less common outside Basenjis.

Acquired Fanconi Syndrome

Dogs of any breed can develop Fanconi syndrome from external triggers. The most well-known acquired cause involves jerky pet treats, particularly chicken and duck jerky products sourced from China. The FDA investigated thousands of illness reports linked to these treats. Complaints dropped noticeably after several products were pulled from shelves in January 2013, when testing revealed low levels of antibiotic residues. Later FDA testing found that over a third of sampled jerky treats contained the antiviral drug amantadine, though no single contaminant was definitively proven to cause the kidney damage. The exact toxic mechanism remains unknown.

Beyond jerky treats, known triggers include nephrotoxins such as ethylene glycol (antifreeze), heavy metals, melamine, and certain medications like gentamicin and azathioprine. Infections such as leptospirosis and underlying conditions like copper-associated liver disease can also damage the proximal tubules enough to cause the syndrome.

Signs to Watch For

The hallmark symptoms are excessive drinking and excessive urination. Because the kidneys are dumping glucose and other nutrients, your dog’s body tries to compensate by pulling in more water, leading to a dramatically increased thirst. You may notice your dog emptying the water bowl far more often than usual and needing to go outside frequently, including overnight.

Other signs that tend to develop over time include:

  • Weight loss and muscle wasting from the chronic loss of amino acids and other nutrients
  • Poor coat condition and a generally run-down appearance
  • Decreased appetite as acidosis worsens
  • Weakness or lethargy from electrolyte imbalances, particularly low potassium and phosphate

In some cases, neurological problems including seizures have been reported. In a study of 60 dogs with idiopathic Fanconi syndrome, 11 experienced seizures or other neurological dysfunction at some point during their illness.

How It’s Diagnosed

Fanconi syndrome is often first suspected when glucose turns up on a routine urine test. This looks alarming because glucose in urine is a classic sign of diabetes. The critical difference is that in diabetes, blood sugar is high, which is why glucose overflows into urine. In Fanconi syndrome, blood sugar is normal or even low, yet glucose still appears in the urine. This combination, called normoglycemic glycosuria, is the diagnostic hallmark.

If your vet finds glucose in your dog’s urine, the next step is checking blood glucose. A normal reading immediately shifts suspicion away from diabetes and toward a proximal tubule problem. Additional urine and blood tests can confirm losses of amino acids, phosphate, and bicarbonate, and assess whether metabolic acidosis has developed. For Basenjis, the genetic test can confirm whether the inherited form is responsible.

Treatment and Daily Management

There is no cure for Fanconi syndrome, but the goal of treatment is to replace what the kidneys are losing. The most widely used approach among veterinary specialists involves oral bicarbonate supplementation to counteract metabolic acidosis, along with replacement of lost electrolytes, vitamins, and amino acids. Blood gas and electrolyte levels are monitored periodically so that supplement doses can be adjusted as the disease progresses or stabilizes.

For dogs with acquired Fanconi syndrome, removing the trigger is the first priority. Dogs whose illness was linked to jerky treats sometimes improve significantly once the treats are discontinued, though some sustain permanent kidney damage.

Day to day, managing a dog with Fanconi syndrome means ensuring constant access to fresh water (they will drink a lot and restricting water is harmful), feeding a high-quality diet to offset nutrient losses, and giving supplements consistently. Regular veterinary checkups with blood and urine monitoring are essential to catch shifts in acid-base balance before they become dangerous.

Long-Term Outlook

The prognosis is more encouraging than many owners expect. A study of 60 dogs with idiopathic Fanconi syndrome, the vast majority of them Basenjis, found a median survival time of 5.25 years after diagnosis. The median estimated lifespan for affected dogs fell between 11.3 and 12.1 years, which is not substantially shorter than the expected lifespan for unaffected dogs of the same breed. Among dogs still alive at the time of the study, 97% of owners rated their dog’s general condition as good to excellent.

These numbers come from dogs managed on a consistent supplementation protocol. Without treatment, the progressive acid buildup and nutrient losses lead to severe muscle wasting, organ damage, and a much shorter life. Early detection through routine urine screening, especially in Basenjis and dogs that have consumed jerky treats, gives the best chance of starting management before significant damage occurs.

Genetic Testing for Breeders and Owners

If you own or are considering purchasing a Basenji, genetic testing is straightforward and widely available through organizations like the Orthopedic Foundation for Animals (OFA). The test identifies whether a dog carries zero, one, or two copies of the FAN1 deletion. Dogs with two copies will almost certainly develop the syndrome. Carriers (one copy) are not expected to develop symptoms but can pass the mutation to offspring. Responsible breeding pairs a carrier only with a clear dog, ensuring no puppies inherit two copies.

For non-Basenji breeds, no genetic test exists because the acquired form has environmental rather than genetic causes. Owners of any breed should be cautious with jerky treats of uncertain origin and watch for early warning signs like increased thirst and urination, particularly in small-breed dogs, which appeared disproportionately affected in FDA reports.